| Dr Arthur Jordan Stanley, MD | |
|
466 Park Manor Dr Nw, Marietta, GA 30064-1461 | |
| (205) 533-0590 | |
| Not Available |
| Full Name | Dr Arthur Jordan Stanley |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 466 Park Manor Dr Nw, Marietta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215348859 | NPI | - | NPPES |
| 83395 | Other | GA | GEORGIA COMPOSITE MEDICAL BOARD |
| Entity Name | Denver Health And Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
The annual premium for a family health plan sponsored by an employer cost about 54 percent more in 2009 than it did in 2000, $13,027 and $8,437 (adjusted for inflation), respectively, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Sound Interventions, Inc. today announced the successful completion of the company's First-In-Human clinical trial (SOUND-ITV) to treat resistant hypertension.
In one study, a team of psychologists used a longitudinal approach to gain a better idea of what to expect after traumatic brain injury (TBI). The researchers found that severe TBI can cause many lasting problems with day-to-day functioning.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center Phase 3 clinical trial, sponsored by Vertex Pharmaceuticals Incorporated, leading to FDA approval of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a highly effective CF treatment, for patients ages 6 through 11 who have at least one copy of the F508del mutation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur Jordan Stanley, MD 466 Park Manor Dr Nw, Marietta, GA 30064-1461 Ph: (205) 533-0590 | Dr Arthur Jordan Stanley, MD 466 Park Manor Dr Nw, Marietta, GA 30064-1461 Ph: (205) 533-0590 |
News Archive
The annual premium for a family health plan sponsored by an employer cost about 54 percent more in 2009 than it did in 2000, $13,027 and $8,437 (adjusted for inflation), respectively, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Sound Interventions, Inc. today announced the successful completion of the company's First-In-Human clinical trial (SOUND-ITV) to treat resistant hypertension.
In one study, a team of psychologists used a longitudinal approach to gain a better idea of what to expect after traumatic brain injury (TBI). The researchers found that severe TBI can cause many lasting problems with day-to-day functioning.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center Phase 3 clinical trial, sponsored by Vertex Pharmaceuticals Incorporated, leading to FDA approval of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a highly effective CF treatment, for patients ages 6 through 11 who have at least one copy of the F508del mutation.
› Verified 1 days ago
Howard E Borger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 355 Tower Rd Ne, Suite 100, Marietta, GA 30060 Phone: 770-424-5669 Fax: 770-424-8454 | |
Dr. Puneet Panda, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 895 Canton Rd Ne, Bldg 100, Marietta, GA 30060 Phone: 770-427-8111 Fax: 678-951-0418 | |
Christopher M Weltz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 355 Tower Rd Ne Ste 100, Marietta, GA 30060 Phone: 770-424-5669 Fax: 770-424-8454 | |
Marc F Greenberg, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 355 Tower Rd Ne Ste 102, Marietta, GA 30060 Phone: 770-422-4055 Fax: 770-528-6977 | |
Gerald E Sanders, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 895 Canton Rd Ne, Building 100, Marietta, GA 30060 Phone: 770-427-8111 Fax: 770-499-1643 | |
Alan L Benedict, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 653 Cherokee St Ne, Marietta, GA 30060 Phone: 770-419-1393 Fax: 770-419-8188 | |
Dr. Amy Marie Cherof, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 895 Canton Rd Ne, Bldg 100, Marietta, GA 30060 Phone: 770-427-8111 Fax: 678-951-0418 |